Showing results (651-660 of 816) with videos related to
Sort By:
Pageof 82
Blood|April 1, 1996
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantationJ E Sanders, J Hawley, W Levy, et al.Blood|April 1, 1993
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresisW I Bensinger, T H Price, D C Dale, et al.Blood|September 1, 1995
Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating plateletsR A Nash, S A Burstein, R Storb, et al.Annals of Internal Medicine|August 1, 1982
Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantationK M Sullivan, R Storb, H M Shulman, et al.Pediatrics|February 1, 1986
Bone marrow transplantation experience for children with aplastic anemiaJ E Sanders, J Whitehead, R Storb, et al.Blood|January 1, 1987
Treatment of preleukemic syndromes with marrow transplantationF R Appelbaum, R Storb, R E Ramberg, et al.Leukemia Research|January 1, 1982
Allogeneic marrow transplantation for acute leukemia in relapseC Badger, C D Buckner, E D Thomas, et al.Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.Bone Marrow Transplantation|December 1, 1994
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemiaC H Weaver, R A Clift, H J Deeg, et al.Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.Pageof 82